Skip to content
An Initiative of AVAC
Search

Resource Library

The PrEPWatch Resource Database offers a wide range of material on the status of PrEP as an option for biomedical HIV prevention around the world. Search this database to find step-by-step guidance for rolling out PrEP, summaries of the research to date on safety, efficacy and implementation, tools to assist planning and roll out, country updates on PrEP policy and access, and lessons learned from those efforts.

Filter By
Multiple filters can be used at once

Showing results 31 - 34 of 34

Selected Filters:
10 October 2019

Social Harms and Use of the Dapivirine Vaginal Ring

The dapivirine ring and other woman-initiated HIV prevention methods are designed to enable women to have more control over their sexual health and risk of HIV exposure, but research has revealed that women's male partners often influence their ability to use these methods. This brief summarizes an analysis of MTN-020/ASPIRE trial data, which showed that…

Research

Document
31 July 2019

Reaching and Targeting More Effectively: The application of market segmentation to improve HIV prevention programmes

A publication by AVAC's Anabel Gomez and others in the Journal of the International AIDS Society explores adapting the use of market segmentation, a traditional tool of the commercial sector, to the promotion of primary HIV prevention.

Demand Creation/Marketing

Document
8 April 2019

Dapivirine Ring Early Introduction Considerations — Malawi Analysis

The OPTIONS Consortium conducted secondary research and interviews with key stakeholders in several countries to understand questions about the ring that could inform demonstration and processes for introducing new biomedical HIV prevention products. Malawi was prioritized for analysis due to the state of the HIV epidemic in the country and experience with ring trials. (For…

Research

Document
8 April 2019

Dapivirine Ring Early Introduction Considerations — Seven Country Analysis

The OPTIONS Consortium conducted secondary research and interviews with key stakeholders in several countries to understand questions about the ring that could inform demonstration and processes for introducing new biomedical HIV prevention products. Rwanda, Uganda, Kenya, Zimbabwe, Malawi, Tanzania and South Africa were prioritized for analysis due to the state of the HIV epidemic in…

Research

Document